🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

RCT of Short-Term Psychoanalytic vs. Cognitive Behavioral Therapy for GAD

RecruitingNAAges 18 Years - 65 YearsAllBeykoz University
NCT06831708 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is a randomized controlled trial designed to compare the effectiveness of two types of short-term psychotherapy-psychoanalytic therapy and Cognitive Behavioral Therapy (CBT)-in treating Generalized Anxiety Disorder (GAD). A total of 60 adult participants with a confirmed diagnosis of GAD will be enrolled and randomly assigned to one of three groups: one group will receive psychoanalytic therapy, a second group will receive CBT, and a third group will serve as a control (waiting list) group. Each treatment group will participate in 12 weekly sessions, with each session lasting 50 minutes. In the psychoanalytic therapy group, therapy will follow a standardized framework based on core psychoanalytic principles such as exploring unconscious conflicts, transference, and resistance. While this approach is flexible, all therapists will be trained and calibrated to apply these core p

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 65 years. * A confirmed diagnosis of Generalized Anxiety Disorder (GAD) according to DSM-5 criteria, with the diagnosis made within the past 2 years. * No participation in any form of psychotherapy during the past 6 months. * Ability and willingness to attend 12 weekly therapy sessions (50 minutes each) over the 3-month intervention period. * For participants receiving online sessions: access to a stable internet connection and the necessary technology. * Ability to understand and provide written informed consent. Exclusion Criteria: * Presence of significant comorbid psychiatric disorders that could interfere with participation or assessment (e.g., bipolar disorder, psychotic disorders, substance use disorders, eating disorders). * Recent changes in psychotropic medication (i.e., medication changes within the past 3 months, unless on a stable dose). * Severe medical or neurological conditions that may interfere with study participation or data interpretation. * Current participation in another clinical trial or structured psychotherapy program. * Any condition that, in the opinion of the investigators, would compromise the safety or compliance of the participant in the study.
💊

What it tests

  • Psychoanalytic Psychotherapy
  • Cognitive Behavioral Therapy (CBT)
📍

Where

1 site
Beykoz University
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy